Anexigen
San Diego
About Anexigen
Anexigen is a developer of novel methods and compositions designed to combat existing and burgeoning antimicrobial threats. The company's platform has the potential to identify novel antibacterial agents with activity against drug-resistant bacteria of biomedical interest and enables functional screening of DNA-encoded peptide-based libraries directly on any Gram-negative pathogen to identify novel antibiotic chemical scaffolds, enabling clinicians and patients to defeat drug-resistant pathogens with the power of Surface Localized Antimicrobial Display (SLAY) platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Jan 2020)
- Website: anexigen.com
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/anexigen-3095586 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.